Your browser doesn't support javascript.
loading
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes.
Garcia-Manero, Guillermo; Diez-Campelo, Maria; Vellenga, Edo; Jacoby, Meagan A; Merchan, Brayan; Breems, Dimitri; Cortelezzi, Agostino; Doronin, Vadim; Gomez, Valle; Beckers, Marielle; Della Porta, Matteo Giovanni; Varsos, Helen; Xiu, Liang; DeAngelis, Nikki; Nnane, Ivo; Rose, Esther; van Eygen, Koen.
  • Garcia-Manero G; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Diez-Campelo M; Hospital Clinico Universitario de Salamanca, Salamanca, Spain.
  • Vellenga E; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Jacoby MA; Washington University School of Medicine, St. Louis, Missouri, USA.
  • Merchan B; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Breems D; Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
  • Cortelezzi A; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milano, Milan, Italy.
  • Doronin V; City Clinical Hospital #40, Moscow, Russia.
  • Gomez V; Hospital Universitario de La Princesa, Madrid, Spain.
  • Beckers M; University Hospital Leuven, Leuven, Belgium.
  • Della Porta MG; Humanitas Clinical and Research Center - IRCCS, Humanitas Cancer Center, Rozzano, Italy.
  • Varsos H; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Xiu L; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • DeAngelis N; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Nnane I; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Rose E; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • van Eygen K; AZ Groeninge, Kortrijk, Belgium.
Am J Hematol ; 96(4): E111-E114, 2021 04 01.
Article en En | MEDLINE | ID: mdl-33448430

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Transfusión de Eritrocitos / Factores Inmunológicos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Transfusión de Eritrocitos / Factores Inmunológicos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article